Sale!

OncoPro Focus Fusion Panel for Solid Tumors Test

Original price was: $1,138.Current price is: $1,024.

-10%

The OncoPro Focus Fusion Panel for Solid Tumors is a comprehensive next-generation sequencing test that analyzes over 50 cancer-related genes to identify specific genetic mutations and fusions driving tumor growth. This advanced molecular diagnostic test provides crucial information for personalized cancer treatment strategies, helping oncologists select targeted therapies based on your tumor’s unique genetic profile. The test detects mutations in key cancer genes including EGFR, KRAS, BRAF, ALK, ROS1, and many others, enabling precision medicine approaches for solid tumors. With results available in 15 working days, this $1024 USD test offers valuable insights for treatment planning and monitoring. Ideal for patients with various solid tumor types seeking targeted treatment options.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

OncoPro Focus Fusion Panel for Solid Tumors Test

Comprehensive Genetic Analysis for Personalized Cancer Treatment

The OncoPro Focus Fusion Panel for Solid Tumors represents a cutting-edge advancement in cancer diagnostics, utilizing next-generation sequencing technology to provide comprehensive genetic profiling of tumor tissue. This sophisticated test analyzes over 50 cancer-related genes to identify specific mutations, fusions, and alterations that drive tumor growth and progression. By understanding the unique genetic makeup of your cancer, healthcare providers can develop highly targeted treatment strategies that are more effective and potentially less toxic than traditional approaches.

What the Test Measures and Detects

The OncoPro Focus Fusion Panel provides detailed analysis of multiple genetic markers including:

  • Gene Mutations: Detects mutations in key cancer genes including AKT1, ALK, BRAF, EGFR, KRAS, NRAS, PIK3CA, and many others
  • Gene Fusions: Identifies fusion events in genes such as ALK, ROS1, RET, NTRK1, NTRK2, and NTRK3
  • Amplifications: Detects gene amplifications including ERBB2 (HER2), CCND1, CDK6, and MYC
  • Multiple Cancer Pathways: Covers critical signaling pathways including MAPK, PI3K/AKT/mTOR, and receptor tyrosine kinases

Who Should Consider This Test

This comprehensive genetic panel is particularly valuable for:

  • Patients diagnosed with solid tumors seeking targeted therapy options
  • Individuals with advanced or metastatic cancer requiring treatment guidance
  • Patients who have failed standard chemotherapy regimens
  • Those with rare or hard-to-treat cancer types
  • Individuals seeking second opinions for cancer treatment
  • Patients with family history of cancer requiring comprehensive genetic assessment

Key Benefits of OncoPro Focus Fusion Panel Testing

  • Personalized Treatment Planning: Identify specific genetic alterations that can be targeted with precision medicines
  • Expanded Treatment Options: Discover eligibility for clinical trials and targeted therapies
  • Improved Outcomes: Potentially better response rates and reduced side effects compared to traditional chemotherapy
  • Comprehensive Analysis: Single test covering multiple genetic alterations instead of multiple individual tests
  • Cost-Effective: Comprehensive panel testing often proves more economical than sequential single-gene testing
  • Future Treatment Guidance: Results may inform treatment decisions throughout your cancer journey

Understanding Your Test Results

Your OncoPro Focus Fusion Panel results will provide detailed information about the genetic alterations detected in your tumor sample. Results typically fall into several categories:

  • Actionable Mutations: Genetic changes with approved targeted therapies available
  • Investigational Targets: Alterations that may qualify you for clinical trials
  • Prognostic Markers: Genetic information that helps predict disease course
  • Resistance Mutations: Changes that may indicate resistance to certain treatments

Your oncologist will interpret these results in the context of your specific cancer type, stage, and overall health to develop the most appropriate treatment plan. It’s important to discuss all findings with your healthcare provider to fully understand their implications for your care.

Test Pricing Information

Price Type Amount (USD)
Discount Price $1024
Regular Price $1138

Sample Requirements and Processing

The test requires submission of formalin-fixed paraffin-embedded (FFPE) tissue block with at least 10% tumor tissue content. Samples should be shipped at room temperature, and results are typically available within 15 working days from sample receipt.

Nationwide Accessibility

We have diagnostic centers conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures that patients nationwide have access to this advanced genetic testing technology.

Take the Next Step in Your Cancer Care

Don’t leave your treatment options to chance. The OncoPro Focus Fusion Panel for Solid Tumors provides the comprehensive genetic information needed to make informed decisions about your cancer treatment. Our team of genetic specialists and oncology experts are ready to help you navigate this important step in your care journey.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your OncoPro Focus Fusion Panel test and take control of your cancer treatment options.